Cambridge, US; Mainz, Germany | full time | Job ID: 11146
About the role:
As an Associate Director of Investor Relations, you will be instrumental in shaping and executing BioNTech's communication strategy for the investment community. Your contributions will help elevate investor engagement and optimize company valuation, ensuring alignment with BioNTech’s mission to improve global health through oncology innovation. You will be part of a high-performing team, collaborating closely with senior leaders across diverse functions to build and refine BioNTech’s equity narrative.
In this visible and impactful role, you will foster trust internally and within the investment community, while showcasing our strategic vision, oncology pipeline, and long-term growth potential.
Your Contribution:
A Good Match:
Preferred qualifications: Advanced academic credentials (MBA or Masters Degree) and biopharmaceutical oncology experience.
Your Benefits:
It's our priority to support you:
Apply now - We look forward to your application!
Apply to our Cambridge, US; Mainz, Germanylocation by sending us your documents via our online form. For any questions, contact our talent acquisition team on: + 49 (0) 6131-9084-1291 (Monday-Friday from 1 PM to 3 PM CET).
Job ID 11146 (please always specify if you have any questions)
By submitting your application, you acknowledge that a background check will be conducted as part of the recruitment process in accordance with applicable laws and regulations. If you are considered for the position, BioNTech will conduct the background check through our service provider ‘HireRight’. You will be informed accordingly by your BioNTech-Recruiter.

Biopharmaceutical New Technologies (BioNTech) is a global biotechnology company aspiring to translate science into survival by developing new immunotherapies utilizing the full potential of the immune system to fight cancer and infectious diseases.
BioNTech is headquartered in Mainz, Germany, and operates globally with almost 7.000 pioneers. Our work is powered by one mission: Improving the health of people worldwide. We believe that scientific rigor and passion are the driving forces that are essential for innovative progress.
BioNTech was founded in 2008 by scientists and physicians to translate science into survival by combining fundamental research and operational excellence. At BioNTech, we have been conducting fundamental research of mRNA technologies in the field of individualized cancer medicine for more than a decade. Some of our colleagues, including our co-founders, have been researching and developing mRNA-based vaccines for more than 25 years.
Ready to join us on this journey? Explore the opportunities and become part of a team that aspires to turn bold ideas into real-world solutions: https://www.biontech.com/int/en/home/careers.html
🔗 Privacy Statement: https://www.biontech.com/int/en/home/data-privacy-statement.html
🔗 Imprint: https://www.biontech.com/int/en/home/imprint.html